この専門家をプロジェクトに採用したいですか？ 見積もりを依頼 無料で。
プロフィール詳細
Dr. Sara C.に依頼
United Kingdom
Scientific/Medical Writer - Principal Scientist Expert in Cell and Molecular Biology and Immunology in Drug Discovery
プロフィール概要
専門分野
サービス
Writing
Medical Writing,
Technical Writing,
Copywriting,
Creative Writing,
Audio Transcription,
General Proofreading & Editing
Research
Feasibility Study,
Technology Scouting,
Fact Checking,
Scientific and Technical Research,
Systematic Literature Review
Consulting
Operations Consulting,
Scientific and Technical Consulting
Data & AI
Statistical Analysis,
Image Processing,
Data Cleaning,
Data Processing,
Data Insights
Product Development
Concept Development
職務経験
PROJECT MANAGER AND PRINCIPAL SCIENTIST
BiVictriX Therapeutics Plc
11月 2021 - 7月 2022
Principal Scientist-Head of Biology
BiVictriX Therapeutics Plc
11月 2021 - 7月 2022 
Senior Scientist / Group Manager
Redx Pharma, Plc
4月 2020 - 10月 2021
Senior Scientist, Biology Team Leader
Redx Pharma (United Kingdom)
4月 2020 - 10月 2021
Senior Scientist
Redx Pharma, Plc
10月 2017 - 5月 2020
Senior Scientist
Redx Pharma (United Kingdom)
10月 2017 - 4月 2020
Scientist
Redx Pharma (United Kingdom)
11月 2015 - 9月 2017
Scientist
Redx Pharma, Plc
11月 2015 - 9月 2017
Medical Writer
Letscom S.r.l.
4月 2015 - 10月 2015
Postdoctoral Research Fellow
Ospedale Pediatrico Bambino Gesu
6月 2011 - 4月 2015
EASL (European Association for the Study of the Liver) Sheila Sherlock/Andrew Burroughs Short-term Training Fellowship 2014,
UCL, Institute of Liver and Digestive Health, London, UK
9月 2014 - 11月 2014
Doctoral Research Fellow
Ospedale Pediatrico Bambino Gesu
1月 2008 - 5月 2011
Research Fellow –
Ospedale Pediatrico Bambino Gesu
1月 2007 - 12月 2007
学歴
PhD Immunology and Applied Biotechnology (Interfaculty (Medicine-Biology))
Universita degli Studi di Roma Tor Vergata
10月 2007 - 5月 2011
PhD Immunology and Applied Biotechnology
University of Rome “Tor Vergata”, Interfaculty, Rome, Italy
9月 2007 - 4月 2011
Master Degree in Biology (Department of Mathematics, Physics and Natural Scieces, degree program in Biological Sciences: specialization in Molecular Biology)
Universita degli Studi di Roma La Sapienza
10月 1996 - 7月 2005
認定資格
- 認定資格の詳細は未入力です。
出版物
JOURNAL ARTICLE
Gnani, D., Romito, I., Artuso, S., Chierici, M., De Stefanis, C., Panera, N., Crudele, A., Ceccarelli, S., Carcarino, E., D'Oria, V., et al.(2017). Focal adhesion kinase depletion reduces human hepatocellular carcinoma growth by repressing enhancer of zeste homolog 2 . Cell Death and Differentiation. 24. (5). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 889-902.
Aranburu, A., Piano Mortari, E., Baban, A., Giorda, E., Cascioli, S., Marcellini, V., Scarsella, M., Ceccarelli, S., Corbelli, S., Cantarutti, N., et al.(2017). Human B-cell memory is shaped by age- and tissue-specific T-independent and GC-dependent events . European Journal of Immunology. 47. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 327-344.
Miccheli, A., Capuani, G., Marini, F., Tomassini, A., Praticò, G., Ceccarelli, S., Gnani, D., Baviera, G., Alisi, A., Putignani, L., et al.(2015). Urinary 1 H-NMR-based metabolic profiling of children with NAFLD undergoing VSL#3 treatment . International Journal of Obesity. 39. (7). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1118-1125.
Panera, N., Ceccarelli, S., Nobili, V., Alisi, A.(2015). Targeting FGF19 binding to its receptor system: A novel therapeutic approach for hepatocellular carcinoma . Hepatology. 62. (4). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1324.
Picchianti Diamanti, A., Rosado, M.M., Scarsella, M., Ceccarelli, S., Laganà, B., D'Amelio, R., Carsetti, R.(2015). Increased serum IgM, immunodeficiency, and autoimmunity: A clinical series . International Journal of Immunopathology and Pharmacology. 28. (4). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 547-556.
Ceccarelli, S., Panera, N., Mina, M., Gnani, D., De Stefanis, C., Crudele, A., Rychlicki, C., Petrini, S., Bruscalupi, G., Agostinelli, L., et al.(2015). LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease . Oncotarget. 6. (39). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 41434-41452.
Jahnel, J., Zöhrer, E., Alisi, A., Ferrari, F., Ceccarelli, S., De Vito, R., Scharnagl, H., Stojakovic, T., Fauler, G., Trauner, M., et al.(2015). Serum Bile Acid Levels in Children with Nonalcoholic Fatty Liver Disease . Journal of Pediatric Gastroenterology and Nutrition. 61. (1). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 85-90.
Panera, N., Gnani, D., Crudele, A., Ceccarelli, S., Nobili, V., Alisi, A.(2014). MicroRNAs as controlled systems and controllers in non-alcoholic fatty liver disease . World Journal of Gastroenterology. 20. (41). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 15079-15086.
Ceccarelli, S., Nobili, V., Alisi, A.(2014). Toll-like receptor-mediated signaling cascade as a regulator of the inflammation network during alcoholic liver disease . World Journal of Gastroenterology. 20. (44). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 16443-16451.
Pastore, A., Alisi, A., Di Giovamberardino, G., Crudele, A., Ceccarelli, S., Panera, N., Dionisi-Vici, C., Nobili, V.(2014). Plasma levels of homocysteine and cysteine increased in pediatric NAFLD and strongly correlated with severity of liver damage . International Journal of Molecular Sciences. 15. (11). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 21202-21214.
Alisi, A., Nobili, V., Ceccarelli, S., Panera, N., De Stefanis, C., De Vito, R., Vitali, R., Bedogni, G., Balsano, C., Cucchiara, S., et al.(2014). Plasma high mobility group box 1 protein reflects fibrosis in pediatric nonalcoholic fatty liver disease . Expert Review of Molecular Diagnostics. 14. (6). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 763-771.
Frasinariu, O.E., Ceccarelli, S., Alisi, A., Moraru, E., Nobili, V.(2013). Gut-liver axis and fibrosis in nonalcoholic fatty liver disease: An input for novel therapies . Digestive and Liver Disease. 45. (7). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 543-551.
Vella, S., Gnani, D., Crudele, A., Ceccarelli, S., De Stefanis, C., Gaspari, S., Nobili, V., Locatelli, F., Marquez, V.E., Rota, R., et al.(2013). EZH2 down-regulation exacerbates lipid accumulation and inflammation in in vitro and in vivo NAFLD . International Journal of Molecular Sciences. 14. (12). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 24154-24168.
Ceccarelli, S., Brescia, L.P., Persano, G., Di Florio, F., Locatelli, F.(2013). Il ruolo della fotoaferesi nel trattamento della malattia del trapianto contro l'ospite dei pazienti pediatrici . Pediatric Reports. 5. (SUPPL.1). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 21-24.
Panera, N., Ceccarelli, S., De Stefanis, C., Nobili, V., Alisi, A.(2013). Retinoids counteract insulin resistance and liver steatosis: What's the potential mechanism? . Hepatology. 58. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1185.
Ceccarelli, S., Panera, N., Gnani, D., Nobili, V.(2013). Dual role of microRNAs in NAFLD . International Journal of Molecular Sciences. 14. (4). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 8437-8455.
Alisi, A., Ceccarelli, S., Panera, N., Prono, F., Petrini, S., De Stefanis, C., Pezzullo, M., Tozzi, A., Villani, A., Bedogni, G., et al.(2013). Association between Serum Atypical Fibroblast Growth Factors 21 and 19 and Pediatric Nonalcoholic Fatty Liver Disease . PLoS ONE. 8. (6).
De Vito, R., Alisi, A., Masotti, A., Ceccarelli, S., Panera, N., Citti, A., Salata, M., Valenti, L., Feldstein, A.E., Nobili, V.(2012). Markers of activated inflammatory cells correlate with severity of liver damage in children with nonalcoholic fatty liver disease . International Journal of Molecular Medicine. 30. (1). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 49-56.
Alisi, A., Ceccarelli, S., Nobili, V.(2012). Transient elastography and serum biomarkers: Two-step screening methods for liver fibrosis in non-alcoholic fatty liver disease before liver biopsy . Expert Opinion on Medical Diagnostics. 6. (5). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 377-380.
Alisi, A., Ceccarelli, S., Panera, N., Nobili, V.(2012). Causative role of gut microbiota in non-alcoholic fatty liver disease pathogenesis . Frontiers in Cellular and Infection Microbiology. 2. Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1-4.
Alisi, A., Pastore, A., Ceccarelli, S., Panera, N., Gnani, D., Bruscalupi, G., Massimi, M., Tozzi, G., Piemonte, F., Nobili, V.(2012). Emodin prevents intrahepatic fat accumulation, inflammation and redox status imbalance during diet-induced hepatosteatosis in rats . International Journal of Molecular Sciences. 13. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 2276-2289.
Fierabracci, A., Cascioli, S., Ceccarelli, S., Nobili, V.(2012). T regulatory cell number and function: The autoimmune traits in liver diseases . Journal of Hepatology. 57. (6). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1398-1399.
Ceccarelli, S., Panera, N., Alisi, A., Nobili, V.(2011). Hepatic stellate cell proliferation: A potential role of protein kinase R . Hepatology. 54. (4). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1484-1485.
Rosado, M.M., Picchianti Diamanti, A., Cascioli, S., Ceccarelli, S., Caporuscio, S., D'Amelio, R., Carsetti, R., Laganà, B.(2011). Hyper-IgM, neutropenia, mild infections and low response to polyclonal stimulation: Hyper-IgM syndrome or common variable immunodeficiency? . International Journal of Immunopathology and Pharmacology. 24. (4). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 983-991.
Aranburu, A., Ceccarelli, S., Giorda, E., Lasorella, R., Ballatore, G., Carsetti, R.(2010). TLR ligation triggers somatic hypermutation in transitional B cells inducing the generation of IgM memory B cells . Journal of Immunology. 185. (12). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 7293-7301.
評価とコメント
受注プロジェクト総数:
コメント: